The Tsinghua-backed DNA and RNA sequencing equipment manufacturer has added $63m to its coffers.

QitanTech, a China-based genomics technology developer backed by Tsinghua University, received RMB400m ($63m) in series B funding yesterday co-led by GL Ventures, the venture capital arm of private equity group Hillhouse Capital. CDH Venture and Growth Capital, a fund owned by asset manager CDH Investments, co-led the round, which also included internet company Baidu’s investment…

The rest of this content is only accessible to University Venturing: News, Data, and Events - Global University Venturing Subscribers.

This content is only accessible to subscribers. If you are a subscriber, please sign in. Otherwise, if you would like to try before you buy and haven't previously taken out a free trial, you can do so below. You can also see details on subscriptions by clicking the Subscription Options button.